CRO in Drug Discovery and Preclinical Services

Circle Oncodesign Services

Innovative services & quality deliverables to accelerate your research program

Oncodesign Services is a contract research organization (CRO) specialized in drug discovery whose mission is to contribute to the discovery of innovative therapies against cancers and serious diseases with high medical needs.

Find out more about what we can offer you depending on the stage of development of your drug discovery project!

Patient Data
Our solution: Explore
  • Target Identification
  • Target Validation
Target
Our solution: Drive-IDDS
  • Small Molecule
    including PROTAC
  • Molecular RadioTherapy (MRT)
  • Biologics
Molecule
Our solution: inpact
  • Oncology
  • Inflammation
Drug candidate
Our solution: Solo
  • POC Oncology
  • POC Inflammation
  • COVID-19
  • Pharmaco-Imaging & MRT
  • DMPK – Bioanalysis
  • Microbiome
IND
Our solution: D-vlop
  • Toxicology
  • CMC
  • Clinical Protocol

Our Therapeutic Areas

Infectious disease - Oncodesign Services

Oncology

Since the inception of the company, we have been pioneering in translational pharmacology to study and treat cancer...

Inflammation - Oncodesign Services

Inflammation

We have a big collection of preclinical inflammatory and autoimmune models, covering diseases of the skin, gut, lungs, kidneys, liver and more...

Oncology - Oncodesign Services

Infectious diseases

We have BSL2 and BSL3 facilities and local partnerships allowing infectious diseases models to be run...

Our latest news

Our latest news

06/03/2025

In this Q&A, discover how cooperativity is unlocking new potential in molecular glues and enabling the targeting of previously “undruggable” proteins.

Read more
24/09/2024

In this blog, we deal with overcoming radionuclides supply challenges with innovative solutions by Oncodesign Services

Read more
03/04/2024

In this blog, we pay attention in the development of oncolytic viruses (OVs) which destroy cancer cells and leverage the host immune system to enhance the effect.

Read more